(Q43687641)

English

Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin.

scientific article published in August 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

hypercholesterolemia

0 references

familial hypercholesterolemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

José Martínez-González

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

R Alonso

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Mata

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R De Andres

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B P Villacastin

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Atherosclerosis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

157

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

423-429

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Development of coronary heart disease in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Levels of soluble cell adhesion molecules in patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart diseas

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Circulating adhesion molecules in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Soluble E-selectin is not a marker of unstable coronary plaque in serum of patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Correlation between flow-mediated vasodilatation of the brachial artery and intima-media thickness in the carotid artery in men

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

The role of endothelial cell adhesion molecules in the development of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

The role of neutrophils in myocardial ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900733-4

7 January 2021

Identifiers

10.1016/S0021-9150(00)00733-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

release_n4upca32knecziokf4yrovs47e

1 reference

https://api.fatcat.wiki/v0/release/n4upca32knecziokf4yrovs47e

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472743%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43687641&oldid=2102518141"